Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Human genetic variants of homologous recombination repair genes first found to be associated with Epstein-Barr virus antibody titers in healthy Cantonese.

Shen GP, Pan QH, Hong MH, Qin HD, Xu YF, Chen LZ, Feng QS, Jorgensen TJ, Shugart YY, Zeng YX, Jia WH.

Int J Cancer. 2011 Sep 15;129(6):1459-66. doi: 10.1002/ijc.25759. Epub 2011 Jan 12.

2.

Significance of specific Epstein-Barr virus IgA and elevated IgG antibodies to viral capsid antigens in nasopharyngeal carcinoma patients.

Hadar T, Rahima M, Kahan E, Sidi J, Rakowsky E, Sarov B, Sarov I.

J Med Virol. 1986 Dec;20(4):329-39.

PMID:
3025351
3.

The reliability of IgA antibody to Epstein-Barr virus (EBV) capsid antigen as a test for the diagnosis of nasopharyngeal carcinoma (NPC).

Levine PH, Pearson GR, Armstrong M, Bengali Z, Berenberg J, Easton J, Goepfert H, Henle G, Henle W, Heffner D, Huang A, Hyams VJ, Lanier A, Neel HB, Pilch B, Pointek N, Taylor W, Terebelo H, Weiland L.

Cancer Detect Prev. 1981;4(1-4):307-12.

PMID:
6299561
4.
5.

Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.

Shao JY, Li YH, Gao HY, Wu QL, Cui NJ, Zhang L, Cheng G, Hu LF, Ernberg I, Zeng YX.

Cancer. 2004 Mar 15;100(6):1162-70.

6.
7.

Improved accuracy of detection of nasopharyngeal carcinoma by combined application of circulating Epstein-Barr virus DNA and anti-Epstein-Barr viral capsid antigen IgA antibody.

Leung SF, Tam JS, Chan AT, Zee B, Chan LY, Huang DP, Van Hasselt A, Johnson PJ, Lo YM.

Clin Chem. 2004 Feb;50(2):339-45. Epub 2003 Dec 18.

8.
9.
10.

Subclass reactivity to Epstein-Barr virus capsid antigen in primary and reactivated EBV infections.

Linde A, Andersson J, Lundgren G, Wahren B.

J Med Virol. 1987 Feb;21(2):109-21.

PMID:
3029317
11.

Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, tonsillar carcinoma and control groups.

Oberender H, Nowak R, Donner A, Kunkel M, Gärtner L, Scholtz HJ.

Acta Virol. 1983 May;27(3):277-81.

PMID:
6138990
12.

IgG and IgA antibodies to Epstein-Barr virus in nasopharyngeal carcinoma patients.

Gong SH, Lynn TC, Yang CS.

Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi. 1978 Mar;11(1):8-15.

PMID:
211015
13.
15.
16.

Epstein-Barr virus seroreactivity among unaffected individuals within high-risk nasopharyngeal carcinoma families in Taiwan.

Pickard A, Chen CJ, Diehl SR, Liu MY, Cheng YJ, Hsu WL, Sun B, Hsu MM, Chen IH, Chen JY, Yang CS, Mittl BL, Chou SP, Ruggles DD, Goldstein AM, Hildesheim A.

Int J Cancer. 2004 Aug 10;111(1):117-23.

17.

Antibodies to Epstein-Barr virus-specific DNase and DNA polymerase in the chronic fatigue syndrome.

Jones JF, Williams M, Schooley RT, Robinson C, Glaser R.

Arch Intern Med. 1988 Sep;148(9):1957-60.

PMID:
2843138
18.

Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma.

Shao JY, Huang XM, Yu XJ, Huang LX, Wu QL, Xia JC, Wang HY, Feng QS, Ren ZF, Ernberg I, Hu LF, Zeng YX.

Anticancer Res. 2001 Jul-Aug;21(4B):3021-9.

PMID:
11712805
19.

Sensitivity and specificity of Epstein-Barr virus IGA titer in the diagnosis of nasopharyngeal carcinoma: a three-year institutional review.

Tsang RK, Vlantis AC, Ho RW, Tam JS, To KF, van Hasselt CA.

Head Neck. 2004 Jul;26(7):598-602.

PMID:
15229902
20.

Evaluation of a semi-quantitative ELISA for IgA antibody against Epstein-Barr virus capsid antigen in the serological diagnosis of nasopharyngeal carcinoma.

Chen H, Chi P, Wang W, Li L, Luo Y, Fu J, Zhang L, Liu W.

Int J Infect Dis. 2014 Aug;25:110-5. doi: 10.1016/j.ijid.2014.03.1373. Epub 2014 May 27.

Supplemental Content

Support Center